secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001437749-25-026360
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q2 revenue up 49% to $1.7M; launches CyberDefense Initiative for defense contracts
--------------------------------------------------------------------------------

- Q2 revenue $1.70M vs $1.14M YoY; net loss improved to ($1.17M) or ($0.20)/share from ($1.67M) or ($1.00)/share.
- Gross margin 73% vs 77% YoY due to higher hardware mix; hardware sales surged to $569K from $83K.
- BIO-key launches CyberDefense Initiative targeting military/defense IAM; cites $350B EU defense spending.
- Notes payable reduced by $0.4M in Q2, balance $0.3M; cash $2.3M at June 30, 2025.
- Platform modernization for PortalGuard IDaaS targeted for Q4'25 release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925026360/0001437749-25-026360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925026360/bkyi20250812_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-026360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer